New solvent-free micronization technology expanded at the Darmstadt site in Germany

Manufacturing powders under ISO 13485 and GMP standards with customized particle sizes and broad range of material properties and degradation times
Opening up new innovations in aesthetic applications and medical device manufacturing

Evonik has expanded its capacities for RESOMER® powder biomaterials at its Darmstadt site in Germany. The specialty chemicals company now offers an advanced solvent-free micronization technology to produce custom powders with different particle sizes and material properties. With the new production capacities, Evonik also intends to expand its own portfolio of standard RESOMER® powders for medical devices to open up customized material solutions for precision implants or aesthetic applications.

Evonik’s new technology platform will open up opportunities to collaborate with customers to co-design and manufacture specialized RESOMER® powders with customized particle sizes for a broad range of medical applications. This systems-oriented approach to developing solutions with partners along the value chain is an important part of the 10-year vision adopted by Evonik’s life sciences division, Nutrition & Care, which inspires a customer-centric, systems-thinking mindset.

“Our micronization technology will empower customers to work with powders in the grade that they need - enabling them to further explore other aesthetic and medical treatments with our innovative biomaterials,” said Andreas Karau, global head of Medical Device Solutions at Evonik’s Health Care business line.

Evonik’s solvent-free micronization technology can be offered from small laboratory scale to commercial manufacturing. This allows customers to test and optimize their own formulations with smaller volumes of technical material before ordering larger commercial quantities that are manufactured under ISO 13485 and GMP standards.
www.evonik.com

Tweet